Understanding how hepatitis B virus DNA is formed
Mechanisms of hepatitis B virus cccDNA formation
This study is looking into how the hepatitis B virus makes a special form of its DNA that helps it stick around in the body, and it's for anyone interested in finding new ways to treat chronic hepatitis B infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Princeton University NIH-funded |
| Lab location | 1 site (Princeton, UNITED STATES) |
| Project ID | NIH-10828810 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the formation of covalently closed circular DNA (cccDNA) from the hepatitis B virus (HBV), which is crucial for the virus's persistence in the body. By using advanced techniques in cell culture and mouse models, the study aims to identify key host factors involved in this process and how they can be targeted to disrupt cccDNA formation. The research will explore the kinetics of cccDNA formation and the role of specific proteins in this process, potentially leading to new therapeutic strategies for treating chronic HBV infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic hepatitis B virus infection who are seeking new treatment options.
Not a fit: Patients who do not have chronic hepatitis B virus infection or those with acute infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively eliminate hepatitis B virus from the body, reducing mortality and improving patient outcomes.
How similar studies have performed: Previous research has shown promise in targeting viral DNA mechanisms, indicating that this approach could lead to significant advancements in hepatitis B treatment.
Where this research is happening
Princeton, UNITED STATES
- Princeton University — Princeton, United States (Active)
Researchers
- Principal investigator: Ploss, Alexander — Princeton University
- Study coordinator: Ploss, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.